Home / Inspections / 1202701

FDA Inspection 1202701 — Novo Nordisk Production Ireland Limited

Novo Nordisk Production Ireland Limited — FEI 3002806873

The FDA completed an inspection of Novo Nordisk Production Ireland Limited on October 28, 2022 in Athlone. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 28, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Athlone (Ireland)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1205233 (NAI Wed Apr 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1043417 (NAI Thu Jan 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 993675 (NAI Fri Nov 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 902814 (NAI Fri Nov 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 802376 (NAI Fri Sep 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources